Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.
Salk Institute, La Jolla, California 92037.
T
T
Hunter
J
J
Pines
D000818:Animals; D017209:Apoptosis; D002453:Cell Cycle / Q000502:physiology*; D002455:Cell Division; D019938:Cyclin D1; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D016213:Cyclins / Q000096:biosynthesis / Q000502:physiology*; D004249:DNA Damage; D015870:Gene Expression; D006706:Homeostasis; D006801:Humans; D008938:Mitosis; D008954:Models, Biological; D009154:Mutation; D009369:Neoplasms / Q000473:pathology* / Q000503:physiopathology*; D015513:Oncogene Proteins / Q000096:biosynthesis / Q000502:physiology*; D011519:Proto-Oncogenes; D016196:S Phase
D016213:Cyclins; D015513:Oncogene Proteins; D019938:Cyclin D1; D018844:Cyclin-Dependent Kinases